GALC and Krabbe disease: Similarly, in a canine model of Krabbe disease, i.c.m. injection of AAVHu68-GALC at a total dose of 3E–13 vg led to a more than 7-fold extension in lifespan, accompanied by reductions in neuroinflammation and demyelination.23